Greenberg, Ross S.
Ruddy, Jake A.
Boyarsky, Brian J.
Werbel, William A.
Garonzik-Wang, Jacqueline M.
Segev, Dorry L.
Imus, Philip H.
Article History
Received: 4 June 2021
Accepted: 2 December 2021
First Online: 27 December 2021
Declarations
:
: This study was approved by the Johns Hopkins Institutional Review Board (IRB00248540) and participants provided informed consent electronically. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: D.L.S. has the following financial disclosures: consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, Thermo Fisher Scientific. The other authors of this manuscript have no financial disclosures or conflicts of interest to disclose as described by <i>BMC Cancer.</i>